Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5584526 | Journal of the American Society of Cytopathology | 2017 | 25 Pages |
Abstract
Our series demonstrates evaluation of CSF involvement by hematopoietic malignancy with FCS is more sensitive than and equally specific as CE. Nonetheless, CE remains one of the mainstays in the evaluation of CSF specimens. Optimizing cytologic evaluation through process modifications including decreasing screening area and evaluation of multiple preparations increased the detection rate of malignant cells. As such, optimal CSF evaluation and integration FCS is critical in patient management.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Darren J. MD, Samuel I. MD, Mikhail MD, Allix L. MPH, Oscar MD,